Premium
Recalcitrant Palmoplantar Pustular Psoriasis Treated with Etanercept
Author(s) -
FLORISTAN UXUA,
FELTES ROSA,
RAMÍREZ PALOMA,
ALONSO MARIA LUISA,
De LUCAS RAUL
Publication year - 2011
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.2011.01234.x
Subject(s) - medicine , etanercept , pustular psoriasis , dermatology , psoriasis , adverse effect , plaque psoriasis , palmoplantar pustulosis , generalized pustular psoriasis , tumor necrosis factor alpha
We report a 10‐year‐old boy presenting with palmoplantar pustular psoriasis, resistant to topical and systemic treatments, who was successfully treated with subcutaneous etanercept (0.4 mg/kg) twice a week for 1 month. Maintenance therapy was extended for 18 months in combination with near ultraviolet light therapy without any adverse effect. Etanercept may be a safe and effective alternative for severe palmoplantar pustular psoriasis in children.